Technical Analysis for ARVN - Arvinas, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 33.07 | 1.97% | 0.64 |
ARVN closed down 0.15 percent on Thursday, May 2, 2024, on 83 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 3
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Inside Day | Range Contraction | 1.97% | |
| Gapped Up | Strength | 1.97% | |
| Oversold Stochastic | Weakness | 1.97% | |
| MACD Bullish Signal Line Cross | Bullish | 1.82% | |
| Oversold Stochastic | Weakness | 1.82% | |
| 200 DMA Support | Bullish | 4.09% | |
| Spinning Top | Other | 4.09% | |
| NR7 | Range Contraction | 4.09% | |
| NR7-2 | Range Contraction | 4.09% | |
| Oversold Stochastic | Weakness | 4.09% |
| Alert | Time |
|---|---|
| 10 DMA Support | about 6 hours ago |
| Gapped Up (Full) | about 7 hours ago |
| Rose Above Previous Day's High | about 7 hours ago |
| Rose Above 10 DMA | about 7 hours ago |
| Up 3% | about 7 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/03/2024
Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 53.08 |
| 52 Week Low | 13.57 |
| Average Volume | 745,177 |
| 200-Day Moving Average | 31.32 |
| 50-Day Moving Average | 40.26 |
| 20-Day Moving Average | 34.40 |
| 10-Day Moving Average | 32.87 |
| Average True Range | 1.69 |
| RSI (14) | 32.43 |
| ADX | 26.63 |
| +DI | 18.29 |
| -DI | 28.23 |
| Chandelier Exit (Long, 3 ATRs) | 34.52 |
| Chandelier Exit (Short, 3 ATRs) | 35.97 |
| Upper Bollinger Bands | 38.63 |
| Lower Bollinger Band | 30.18 |
| Percent B (%b) | 0.27 |
| BandWidth | 24.54 |
| MACD Line | -2.31 |
| MACD Signal Line | -2.42 |
| MACD Histogram | 0.1096 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 34.63 | ||||
| Resistance 3 (R3) | 34.62 | 33.88 | 34.26 | ||
| Resistance 2 (R2) | 33.88 | 33.32 | 33.89 | 34.14 | |
| Resistance 1 (R1) | 33.16 | 32.98 | 32.79 | 33.16 | 34.02 |
| Pivot Point | 32.42 | 32.42 | 32.23 | 32.42 | 32.42 |
| Support 1 (S1) | 31.69 | 31.86 | 31.32 | 31.70 | 30.84 |
| Support 2 (S2) | 30.95 | 31.51 | 30.96 | 30.72 | |
| Support 3 (S3) | 30.23 | 30.95 | 30.60 | ||
| Support 4 (S4) | 30.23 |
